90 related articles for article (PubMed ID: 28258323)
1. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
[TBL] [Abstract][Full Text] [Related]
2. Machine Learning Methods Based on CT Features Differentiate G1/G2 From G3 Pancreatic Neuroendocrine Tumors.
Chen HY; Pan Y; Chen JY; Chen J; Liu LL; Yang YB; Li K; Ma Q; Shi L; Yu RS; Shao GL
Acad Radiol; 2024 May; 31(5):1898-1905. PubMed ID: 38052672
[TBL] [Abstract][Full Text] [Related]
3. Primary hepatic neuroendocrine neoplasms: imaging characteristics and misdiagnosis analysis.
Yang XR; Li YL; Li ZY; Chai XM
Front Oncol; 2024; 14():1391663. PubMed ID: 38807765
[TBL] [Abstract][Full Text] [Related]
4. Analysis of MRI features and associated factors of the pituitary neuroendocrine tumor streaky sign.
Zhong J; Zhang H; Chen Y; Li J; Wei L; Wang S
J Clin Ultrasound; 2024 May; ():. PubMed ID: 38769745
[TBL] [Abstract][Full Text] [Related]
5. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents.
Pavel M; Valle JW; Eriksson B; Rinke A; Caplin M; Chen J; Costa F; Falkerby J; Fazio N; Gorbounova V; de Herder W; Kulke M; Lombard-Bohas C; O'Connor J; Sorbye H; Garcia-Carbonero R; ;
Neuroendocrinology; 2017; 105(3):266-280. PubMed ID: 28351033
[No Abstract] [Full Text] [Related]
6. Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.
Parghane RV; Talole S; Prabhash K; Basu S
Clin Nucl Med; 2017 Jun; 42(6):428-435. PubMed ID: 28319500
[TBL] [Abstract][Full Text] [Related]
7. Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours.
Lepage C; Dahan L; Bouarioua N; Toumpanakis C; Legoux JL; Le Malicot K; Guimbaud R; Smith D; Tougeron D; Lievre A; Cadiot G; Di Fiore F; Bouhier-Leporrier K; Hentic O; Faroux R; Pavel M; Borbath I; Valle JW; Rinke A; Scoazec JY; Ducreux M; Walter T
Dig Liver Dis; 2017 May; 49(5):568-571. PubMed ID: 28292641
[TBL] [Abstract][Full Text] [Related]
8. Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.
Cives M; Strosberg J
Curr Treat Options Oncol; 2017 Mar; 18(3):14. PubMed ID: 28286921
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement.
Davar J; Connolly HM; Caplin ME; Pavel M; Zacks J; Bhattacharyya S; Cuthbertson DJ; Dobson R; Grozinsky-Glasberg S; Steeds RP; Dreyfus G; Pellikka PA; Toumpanakis C
J Am Coll Cardiol; 2017 Mar; 69(10):1288-1304. PubMed ID: 28279296
[TBL] [Abstract][Full Text] [Related]
10. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
[TBL] [Abstract][Full Text] [Related]
11. Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome.
Shi DD; Yuppa DP; Dutton T; Brais LK; Minden SL; Braun IM; Kulke MH; Chan JA; Meyer FL
Cancer; 2017 Jul; 123(14):2735-2742. PubMed ID: 28267211
[TBL] [Abstract][Full Text] [Related]
12. A Novel Observational Strategy for Nonfunctional Pancreatic Neuroendocrine Neoplasms With Texture Analysis: A Multicenter Retrospective Study.
Shiozaki H; Gocho T; Shirai Y; Takano Y; Ohki K; Suka M; Okamoto T; Fujioka S; Toya N; Ikegami T
Cancer Diagn Progn; 2023; 3(5):543-550. PubMed ID: 37671308
[TBL] [Abstract][Full Text] [Related]
13. Can solid pseudopapillary neoplasm of the pancreas without degeneration be diagnosed with imaging? a comparison study of the solid component of solid pseudopapillary neoplasm, neuroendocrine neoplasm, and ductal adenocarcinoma.
Toshima F; Inoue D; Kozaka K; Komori T; Takamatsu A; Katagiri A; Gabata T
Abdom Radiol (NY); 2023 Mar; 48(3):936-951. PubMed ID: 36708377
[TBL] [Abstract][Full Text] [Related]
14. Nomogram for preoperative estimation of histologic grade in gastrointestinal neuroendocrine tumors.
Wu ZQ; Li Y; Sun NN; Xu Q; Zhou J; Su KK; Goyal H; Xu HG
Front Endocrinol (Lausanne); 2022; 13():991773. PubMed ID: 36353229
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Computed Tomography Image Analysis to Predict Pancreatic Neuroendocrine Tumor Grade.
Pulvirenti A; Yamashita R; Chakraborty J; Horvat N; Seier K; McIntyre CA; Lawrence SA; Midya A; Koszalka MA; Gonen M; Klimstra DS; Reidy DL; Allen PJ; Do RKG; Simpson AL
JCO Clin Cancer Inform; 2021 Jun; 5():679-694. PubMed ID: 34138636
[TBL] [Abstract][Full Text] [Related]
16. Correlation between radiologic features on contrast-enhanced CT and pathological tumor grades in pancreatic neuroendocrine neoplasms.
Xu W; Yan H; Xu L; Li M; Gao W; Jiang K; Wu J; Miao Y
J Biomed Res; 2020 Aug; 35(3):179-188. PubMed ID: 33637654
[TBL] [Abstract][Full Text] [Related]
17. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms.
Saleh M; Bhosale PR; Yano M; Itani M; Elsayes AK; Halperin D; Bergsland EK; Morani AC
Abdom Radiol (NY); 2022 Sep; 47(9):3078-3100. PubMed ID: 33095312
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging radiomic analysis can preoperatively predict G1 and G2/3 grades in patients with NF-pNETs.
Bian Y; Li J; Cao K; Fang X; Jiang H; Ma C; Jin G; Lu J; Wang L
Abdom Radiol (NY); 2021 Feb; 46(2):667-680. PubMed ID: 32808056
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Neuroendocrine Neoplasm Invading the Entire Main Pancreatic Duct Diagnosed by a Preoperative Endoscopic Biopsy.
Kimura T; Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kofunato Y; Kimura T; Yamada S; Hashimoto Y; Marubashi S; Hikichi T; Ohira H
Intern Med; 2020 Aug; 59(16):1991-1996. PubMed ID: 32448838
[TBL] [Abstract][Full Text] [Related]
20. Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors.
Bian Y; Zhao Z; Jiang H; Fang X; Li J; Cao K; Ma C; Guo S; Wang L; Jin G; Lu J; Xu J
J Magn Reson Imaging; 2020 Oct; 52(4):1124-1136. PubMed ID: 32343872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
